FDA Grants AP Status for Metformin Hydrochloride ANDA202306
The FDA has granted Abbreviated Approval (AP) status for ANDA202306, a generic formulation of Metformin Hydrochloride.
Asset / Drug
Drug and asset intelligence for Platinum with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.